Phreesia (PHR) is expected to report a quarterly loss of $0.13 per share, marking a significant increase of 62.9% compared to the same period last year. Analysts anticipate revenues will reach $114.69 million, representing a 13.3% growth year-over-year. The consensus EPS estimate has remained stable over the past month, reflecting a steady outlook by covering analysts.
As companies approach earnings announcements, changes in earnings estimates play a critical role in understanding potential investor reactions. Research has shown a strong link between earnings estimate trends and short-term stock price movements.
Diving into specific revenue projections, analysts estimate that revenues from subscription and related services will reach $52.43 million, a 12.2% increase from last year. Network solutions revenue is projected at $33.40 million, suggesting a notable year-over-year growth of 21.8%. Additionally, payment processing fees are expected to total $28.87 million, a 6.7% increase compared to the previous year.
Analysts are optimistic about Phreesia’s performance metrics as well, estimating an average of 4,373 healthcare services clients, up from 4,065 in the same quarter last year. The average revenue per healthcare services client is anticipated to rise to $18.65 million, up from $18.24 million the previous year. Patient payment volume is also expected to grow, predicted at $1.25 billion compared to $1.17 billion last year.
However, shares of Phreesia have decreased by 2.8% over the past month, while the Zacks S&P 500 composite gained 8.2%. Currently holding a Zacks Rank of #3 (Hold), Phreesia is projected to closely follow the overall market performance in the near term.
Despite the recent dip in stock performance, the forecasted revenue growth and client metrics indicate potential for recovery and improvement. As Phreesia continues to expand its services and enhance its client base, investors may find reasons for optimism in the company’s financial trajectory moving forward.